Safety and Regulatory Status of Saccharin and Stevia
Regulatory Approval and Contraindications
- The World Health Organization does not list any contraindications for saccharin or stevia, indicating both are considered safe for the general population. 1
- The U.S. Food and Drug Administration has approved saccharin for use since 1879 and reports no contraindications. 1
- The U.S. Food and Drug Administration granted stevia a “Generally Recognized as Safe” (GRAS) designation in 2015, with no identified safety concerns. 1
Sweetness Intensity and Caloric Content
- Saccharin provides approximately 200–700 × the sweetness of sucrose while contributing zero calories. 1
- Stevia delivers roughly 200–400 × the sweetness of sucrose, contains zero calories, and remains stable when heated. 1
Pediatric Safety Endorsement
- The American Academy of Pediatrics endorses stevia as safe for consumption by children. 3
Acceptable Daily Intake (ADI) and General Use
- Both saccharin and stevia fall within established acceptable daily intake (ADI) limits and are deemed safe by the FDA and other international regulatory agencies. 3
- From a safety perspective, saccharin and stevia are appropriate for use in the general population, including pediatric patients. 1
Emerging Therapeutic Evidence
- Preliminary data suggest stevia may exert modest anti‑inflammatory and nephroprotective effects in patients with early‑stage chronic kidney disease. 3